Research News
Research News
-
Curing HIV—How Far Have We Come?
It can be hard to keep track of the various cases of HIV having been cured or controlled in the absence of antiretroviral therapy. amfAR has put together a helpful summary.
-
Best Supporting Actors: Other Immune Cells Shaping the Future of HIV Research
Along with T cells, researchers are studying B cells, natural killer (NK) cells, and macrophages to discover how immune cells might work in new HIV therapies.
-
Remembering Loreen Willenberg, HIV Advocate Who Expanded the Boundaries of Cure Research
Loreen Willenberg was a pioneering HIV advocate and elite controller whose unique immune response helped advance HIV cure research.
-
Innovation at the Intersections of HIV and Brain Health
Dr. Andrea Gramatica, VP of Research, and Dr. Kelsey Hopland, Program Officer, Research, discuss a new set of questions about brain health as people age with HIV and the possible answers found in scientific advances.
-
The Role of Killer T Cells in an HIV Cure Strategy
An amfAR-supported HIV cure study investigates the timing of HIV-specific CD8+ “killer” T cell responses and the suppression of HIV reservoirs.
-
What’s on the Treatment and Cure Horizon for HIV and Cancer?
Researchers testing innovative technologies and therapeutic strategies that have applications across cancer and HIV are making meaningful progress.
-
The Promise of Immunotherapy to Cure HIV
A groundbreaking amfAR-funded HIV cure study using immunotherapy leads to potential breakthroughs in controlling the virus long-term.
-
How T Cells Are Defining the Future of HIV Therapies and Beyond
Research into T cells holds the potential to make advances in HIV therapies and the treatment of conditions such as cancer and autoimmune diseases.
-
“Elite Controllers” Provide Clues for an HIV Cure Strategy
Researchers look to “elite controllers,” people with a natural ability to control HIV, for more answers about the role of immunity in an HIV cure.
-
amfAR Awards New HIV Cure-Focused Research Grants Totaling $2.4 Million
amfAR awards new research grants totaling $2.4 million for projects focused on a global HIV cure: scalable, accessible, and applicable for all.
-
The Importance of Sex in HIV Cure Strategies
A new amfAR-funded study led by Drs. Xu G. Yu and Mathias Lichterfeld suggests that sex differences influence the HIV reservoir, the main barrier to a cure.
-
How mRNA Could Help Create an HIV Vaccine
In a new study, researchers show potential of mRNA technology to provide a workaround for creating an effective immune response as part of an HIV vaccine.
-
amfAR Awards Boost Aspiring HIV Researchers
At a critical time for funding, amfAR awards four Mathilde Krim fellowships to early-career researchers studying innovative strategies to cure HIV.
-
Landmark Supreme Court Decision Protects Free Access to PrEP, Preventive Healthcare
The Court’s ruling upholds a key provision of the Affordable Care Act and represents an important victory for HIV prevention and health equity
-
Researchers Target and Awaken Dormant HIV in Groundbreaking Advance
Researchers use lipid nanoparticles—LNP X—to insert mRNA capable of targeting and awakening dormant HIV, the main barrier to a cure.